Price $82.01 |
Market Cap
6.94B
|
Sector Health Care |
Div. Growth
11.20%
|
|
P/E
63.9
|
P/B
2.47
|
P/S
2.65
|
Dividend %
1.40%
|
|
P/CF
205.0
|
P/FCF
44.3
|
Op. Cash Flow
424.1K
|
FCF
1.8
|
|
Op. Margin
8.70%
|
Net Margin
4.20%
|
ROE
3.80%
|
ROI
3.60%
|
|
ROA
2.20%
|
EPS Growth
-13.50%
|
Current Ratio
2.7
|
Debt/Equity
52.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Aralez Pharmaceuticals Inc (ARLZ) | $1.24 | - | - | 91.5M | Strong Buy |
| BioLife Solutions Inc (BLFS) | $3.42 | - | - | 30.8M | Strong Buy |
| Biostar Pharmaceuticals Inc (BSPM) | $1.49 | - | - | 4M | Strong Buy |
| Birner Dental Mgmt Services In (BDMS) | $12.25 | - | 6.50% | 25.1M | Strong Buy |
| Momenta Pharmaceuticals, Inc. (MNTA) | $16.30 | - | - | 1.27B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
